These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 269414)

  • 21. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K
    Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocerebrosidase for treatment of Gaucher's disease: first German long-term results.
    Niederau C; Holderer A; Heintges T; Strohmeyer G
    J Hepatol; 1994 Oct; 21(4):610-7. PubMed ID: 7814809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies.
    Beutler E; Dale GL
    Prog Clin Biol Res; 1982; 95():703-16. PubMed ID: 7122644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
    MacKenzie JJ; Amato D; Clarke JT
    CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.
    Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM
    Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of glucocerebroside beta-glucosidase for entrapment in liposomes and treatment of patients with adult Gaucher's disease.
    Braidman I; Gregoriadis G
    Biochem Soc Trans; 1976; 4(2):259-61. PubMed ID: 1001662
    [No Abstract]   [Full Text] [Related]  

  • 27. [Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy].
    Castelló Girona F; Domínguez Luengo C; del Toro Riera M; Chabás Bergon A
    An Esp Pediatr; 2001 Mar; 54(3):310-2. PubMed ID: 11262263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imiglucerase and its use for the treatment of Gaucher's disease.
    Weinreb NJ
    Expert Opin Pharmacother; 2008 Aug; 9(11):1987-2000. PubMed ID: 18627336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the turnover of exogenous mannose-terminal glucocerebrosidase in rat liver lysosomes.
    Murray GJ; Oliver KL; Jin FS; Brady RO
    J Cell Biochem; 1995 Feb; 57(2):208-17. PubMed ID: 7759558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of Gaucher's disease phenotypes with monoclonal antibody.
    Ginns EI; Tegelaers FP; Barneveld R; Galjaard H; Reuser AJ; Brady RO; Tager JM; Barranger JA
    Clin Chim Acta; 1983 Jul; 131(3):283-7. PubMed ID: 6883722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological features in Gaucher's disease during enzyme replacement therapy.
    Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N
    Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.
    Shaaltiel Y; Gingis-Velitski S; Tzaban S; Fiks N; Tekoah Y; Aviezer D
    Plant Biotechnol J; 2015 Oct; 13(8):1033-40. PubMed ID: 25828481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gaucher's disease: therapy by intravenous infusions of modified glucocerebrosidase.
    Beck M; Valadares ER; Lotz J
    Clin Investig; 1993 Jan; 71(1):78. PubMed ID: 8453266
    [No Abstract]   [Full Text] [Related]  

  • 39. Mammalian glucocerebrosidase: implications for Gaucher's disease.
    Glew RH; Basu A; LaMarco KL; Prence EM
    Lab Invest; 1988 Jan; 58(1):5-25. PubMed ID: 3275832
    [No Abstract]   [Full Text] [Related]  

  • 40. Initiation of enzyme replacement therapy for an adult patient with asymptomatic type 1 Gaucher's disease.
    Tanaka N; Saito H; Ito T; Momose K; Ishida F; Hora K; Kiyosawa K; Ida H
    Intern Med; 2001 Aug; 40(8):716-21. PubMed ID: 11518109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.